A disease-modifying therapy for retinal degenerations by drug repurposing

被引：0

作者：

Leinonen, Henri Olavi ^{[1
,2
]}

Zhang, Jianye ^{[1
,2
]}

Gao, Fangyuan ^{[1
,2
]}

Choi, Elliot H. ^{[1
,2
]}

Einstein, Elliott E. ^{[3
]}

Einstein, David E. ^{[4
]}

Occelli, Laurence Mireille ^{[5
]}

Marinho, Luis Felipe ^{[5
]}

Kolesnikov, Alexander V. ^{[6
]}

Kefalov, Vladimir ^{[6
]}

Skowronska-Krawczyk, Dorota ^{[1
,2
]}

Blackshaw, Seth ^{[7
]}

Petersen-Jones, Simon M. ^{[5
]}

Palczewski, Krzysztof ^{[1
,2
]}

机构：

[1] Univ Calif Irvine, Ophthalmol, Irvine, CA USA

[2] Univ Calif Irvine, Gavin Herbert Eye Inst, Irvine, CA USA

[3] Univ Calif Irvine, Sch Biol Sci, Irvine, CA USA

[4] Univ Calif Irvine, Physiol Biophys, Irvine, CA USA

[5] Michigan State Univ, Coll Vet Med, Small Anim Clin Sci, E Lansing, MI 48824 USA

[6] Washington Univ, Ophthalmol & Visual Sci, St Louis, MO 63110 USA

[7] Johns Hopkins Univ, Neurosci, Baltimore, MD USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2021年 / 62卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

3157

引用

页数：4

共 50 条

[31] Neuromodulation as a Potential Disease-Modifying Therapy for Osteoarthritis
Cruz, Carlos J.
Dewberry, L. Savannah
Otto, Kevin J.
Allen, Kyle D.
CURRENT RHEUMATOLOGY REPORTS, 2023, 25 (01) : 1 - 11
[32] Symptomatic and disease-modifying therapy for the progressive ataxias
Perlman, SL
NEUROLOGIST, 2004, 10 (05) : 275 - 289
[33] Multiple sclerosis disease-modifying therapy and pregnancy
Miller, Aaron E.
MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (06) : 715 - 716
[34] Factors that influence compliance with disease-modifying therapy
Treadaway, K
Hawker, K
Racke, M
Brannon, K
Morrison, A
Remington, G
Frohman, E
JOURNAL OF NEUROLOGY, 2005, 252 : 110 - 111
[35] Polyphenols as the Potential Disease-modifying Therapy in Cancer
Rogovskii, Vladimir
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2022, 22 (13) : 2385 - 2392
[36] Disease-Modifying Therapy of Pediatric Multiple Sclerosis
Chitnis, Tanuja
NEUROTHERAPEUTICS, 2013, 10 (01) : 89 - 96
[37] Neuromodulation as a Potential Disease-Modifying Therapy for Osteoarthritis
Carlos J. Cruz
L. Savannah Dewberry
Kevin J. Otto
Kyle D. Allen
Current Rheumatology Reports, 2023, 25 : 1 - 11
[38] Huperzine A: is it an effective disease-modifying drug for Alzheimer's disease?
Qian, Zhong Ming
Ke, Ya
FRONTIERS IN AGING NEUROSCIENCE, 2014, 6
[39] EXPERT CONSENSUS EXPLORING THE DEFINITION OF A DISEASE-MODIFYING THERAPY, AND THE DATA REQUIRED TO ESTABLISH A THERAPY AS DISEASE-MODIFYING IN PULMONARY ARTERIAL HYPERTENSION
McLaughlin, Vallerie
Frantz, Robert P.
Hemnes, Anna R.
Rahaghi, Franck
Sahay, Sandeep
Strachan, Paul M.
Lopez, David
Lam, Jenny
Cho, Michelle
Stone, Medi
Bridge, Daisy
Perry, Richard
Enstone, Ashley
Perrett, Lisa
Smith, Holly
Doad, Gurinderpal
CHEST, 2024, 166 (04) : 5763A - 5767A
[40] Disease-modifying effects of ranibizumab for central retinal vein occlusion
Jason M. Huang
Rahul N. Khurana
Avanti Ghanekar
Pin-wen Wang
Bann-Mo Day
Barbara A. Blodi
Amitha Domalpally
Carlos Quezada-Ruiz
Michael S. Ip
Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 799 - 805

← 1 2 3 4 5 →